Should patient compliance be included in pharmaco-economic evaluations? An explorative analysis in Germany

被引：0
|
作者：
Schalk, Katharina [1 ]
Thanner, Mirjam [1 ]
Loss, Julika [1 ]
Jaeger, Anne [1 ]
Nagel, Eckhard [1 ]
机构：
[1] Univ Bayreuth, Inst Hlth Care Sci & Management Med, Bayreuth, Germany
来源：
PHARMACY WORLD & SCIENCE | 2009年 / 31卷 / 02期
关键词：
Compliance; Pharmaco-economic evaluation; Sensitivity analysis;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [1] Issues for statisticians in pharmaco-economic evaluations
    Grieve, AP
    STATISTICS IN MEDICINE, 1998, 17 (15-16) : 1715 - 1723
  • [2] Pharmaco-economic evaluations of the treatment of osteoporosis: A review
    Christensen, PM
    Brosen, K
    Brixen, KT
    Beck-Nielsen, H
    Sogaard, J
    Kristiansen, IS
    UGESKRIFT FOR LAEGER, 2002, 164 (10) : 1339 - 1345
  • [3] Economic and pharmaco-economic analysis of acromegaly treatment: a systematic review
    Kamusheva, Maria
    Rusenova, Yanitsa
    Vandeva, Silvia
    Elenkova, Atanaska
    Zaharieva, Sabina
    Doneva, Miglena
    Mitkova, Zornitsa
    Petrova, Guenka
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2019, 33 (01) : 1560 - 1571
  • [4] A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss
    Treur, Maarten
    Heeg, Bart
    Moeller, Hans-Juergen
    Schmeding, Annette
    van Hout, Ben
    BMC HEALTH SERVICES RESEARCH, 2009, 9
  • [5] A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss
    Maarten Treur
    Bart Heeg
    Hans-Jürgen Möller
    Annette Schmeding
    Ben van Hout
    BMC Health Services Research, 9
  • [6] Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France
    Boecking, Wolfgang
    Klamar, Anna
    Kitzmann, Florian
    Kirch, Wilhelm
    BMC PUBLIC HEALTH, 2012, 12
  • [7] Guidelines for pharmaco-economic research in relation to published health-economics evaluations
    Postma, MJ
    Kwik, JJ
    Rutten, WJMJ
    de Jong-van den Berg, LTW
    Brouwers, JRBJ
    NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE, 2002, 146 (23) : 1082 - 1087
  • [8] What pharmaco-economic criteria should be considered when using glycopeptides?
    Zambrowski, JJ
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : S103 - S105
  • [9] Priming the circle system with sevoflurane: A pharmaco-economic analysis
    Epstein, RH
    Marr, AT
    Guvakov, D
    ANESTHESIOLOGY, 1996, 85 (3A) : A447 - A447
  • [10] Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France
    Wolfgang Boecking
    Anna Klamar
    Florian Kitzmann
    Wilhelm Kirch
    BMC Public Health, 12
12345